Vaccine Therapy in Stage II, III, or IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancers

NCT00803569 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Fallopian Tube Cancer
Ovarian Cancer
Peritoneal Cavity Cancer

Interventions

BIOLOGICAL: ALVAC(2)-NY-ESO-1(M)/TRICOM vaccine
BIOLOGICAL: Sargramostim

Sponsor

Ludwig Institute for Cancer Research

Collaborators

[object Object]
[object Object]